Bioequivalency Study of Famciclovir 500 mg Tablets Under Fasted Conditions

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Herpes Clinical Trial

Official title:
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Famciclovir Tablets Under Fasting Conditions

Status Completed

Clinical Trial Summary

The objective of this study was to prove the bioequivalence of Famciclovir 500 mg Tablets under fasting conditions.

n/a

See also
Status	Clinical Trial	Phase
Completed	`NCT04664127` - Study of the Efficacy and Safety of Combined Treatment of Patients With Severe Herpes Simplex (HSV) Infection by Valacyclovir and Interferon Inducer Kagocel
Completed	`NCT01321502` - Bioequivalency Study of Famciclovir 500 mg Tablets Under Fed Conditions	N/A
Completed	`NCT02092233` - A Two Arm, Multi-Site Clinical Evaluation of the ARIES HSV 1&2 Assay in Symptomatic Patients	N/A
Completed	`NCT01477879` - Hsv 1 and 2 Gowey Protocol Versus Placebo	Phase 1/Phase 2
Completed	`NCT00362596` - A Randomized Controlled Trial of Acyclovir Among HIV and HSV-2 Co-Infected Women, Chiang Rai, Thailand	Phase 4